(2E)-3-phenyl-2-nitroprop-2-enenitrile | 38436-36-1

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: (2E)-3-phenyl-2-nitroprop-2-enenitrile
• 英文别名: α-nitrocinnamonitrile trans；(E)-1-cyano-1-nitro-2-phenylethene；(E)-1-cyano-2-phenyl-1-nitroethene；(E)-2-phenyl-1-cyano-1-nitroethene；(E)-3-phenyl-2-nitropropenonitrile；α-nitro-cis-cinnamonitrile；(E)-2-nitro-3-phenylprop-2-enenitrile
• CAS: 38436-36-1；37630-63-0
• 化学式: C₉H₆N₂O₂
• 分子量: 174.159
• InChiKey: LUBZISVMDWFFEL-RMKNXTFCSA-N

物化性质

• 熔点：
  103-104 °C
• 沸点：
  298.7±28.0 °C(Predicted)
• 密度：
  1.277±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.1
• 重原子数：
  13
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  69.6
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  (2E)-3-phenyl-2-nitroprop-2-enenitrile 生成 2,4-Dinitro-3-phenylpentanedinitrile
  参考文献：
  名称：

  DEMIREVA Z. I.; POLYANSKAYA A. S.; MLADENOV I.; PEREKALIN V. V., ZH. ORGAN. XIMII , 1976, 12, HO 6, 1192-1197

  摘要：

  DOI：
• 作为产物：
  描述：

  硝基乙腈 、 苯甲醛 以64%的产率得到
  参考文献：
  名称：

  BLAHA I.; LESETICKY L., COLLECT. CZECHOSL. CHEM. COMMUN., 51,(1986) N 5, 1094-1099

  摘要：

  DOI：

文献信息

• Amberlite IRA900F as a Solid Fluoride Source for a Variety of Organic Transformations under Solvent-Free Conditions
  作者：Francesco Fringuelli、Daniela Lanari、Ferdinando Pizzo、Luigi Vaccaro

  DOI：10.1002/ejoc.200800142

  日期：2008.8

  We have reported that Amberlite IRA900F (Amb-F) is an efficient metal-free catalyst for the activation of Si–N and Si–O bonds and a mild base in a variety of organic transformations under solvent-free conditions, such as the addition of TMSN3 to (E)-2-aryl-1-cyano-1-nitroethenes, nitriles, α,β-unsaturated acids and their esters, and the addition of dimethylsilylketene acetal and ethyl nitroacetate

  我们已经报道，Amberlite IRA900F (Amb-F) 是一种有效的无金属催化剂，用于在无溶剂条件下激活 Si-N 和 Si-O 键和各种有机转化中的温和碱，例如添加将 TMSN3 转化为 (E)-2-芳基-1-氰基-1-硝基乙烯、腈、α,β-不饱和酸及其酯，以及将二甲基甲硅烷基乙烯酮缩醛和硝基乙酸乙酯加成到 β-硝基苯乙烯。（© Wiley-VCH Verlag GmbH & Co. KGaA, 69451 Weinheim, Germany, 2008)
• NOVEL TRICYCLIC CHIRAL COMPOUNDS AND THEIR USE IN ASYMMETRIC CATALYSIS
  申请人：Loh Teck Peng

  公开号：US20110269972A1

  公开（公告）日：2011-11-03

  The present invention relates to a compound of general Formula (XX), its formation and its use in asymmetric catalysis. In Formula (XX) R and R 31 are independently —COOR 3 , —R 4 COOR 3 , —R 4 CHO, —R 4 COR 3 , —R 4 CONR 5 R 6 , —R 4 COX, —R 4 OP(═O)(OH) 2 , —R 4 P(═O)(OH) 2 ), —R 4 C(O)C(R 3 )CR 5 R 6 and —R 4 CO 2 COR 3 . In addition, R 31 may also be hydrogen. R 3 , R 5 and R 6 are independently hydrogen, an aliphatic group with a main chain having 1 to about 20 carbon atoms, an alicyclic group, an aromatic group, an arylaliphatic group or an arylalicyclic group, comprising 0 to about 3 heteroatoms independently selected from the group consisting of N, O, S, Se and Si. R 4 an aliphatic bridge with a main chain having 1 to about 20 carbon atoms, an alicyclic bridge, an aromatic bridge, an arylaliphatic bridge or an arylalicyclic bridge, comprising 0 to about 3 heteroatoms independently selected from the group consisting of N, O, S, Se and Si, and X is halogen. In Formula (XX) R 30 is —C(OH)R 1 R 2 or —COOR 14 , wherein R 1 , R 2 and R 14 are independently hydrogen, an aliphatic group with a main chain having 1 to about 20 carbon atoms, an alicyclic group, an aromatic group, an arylaliphatic group or an arylalicyclic group, comprising 0 to about 3 heteroatoms independently selected from the group consisting of N, O, S, Se and Si.

  本发明涉及一种一般式（XX）的化合物，其形成以及在不对称催化中的应用。在式（XX）中，R和R31独立地为—COOR3，—R4COOR3，—R4CHO，—R4COR3，—R4CONR5R6，—R4COX，—R4OP(═O)(OH)2，—R4P(═O)(OH)2，—R4C(O)C(R3)CR5R6和—R4CO2COR3。此外，R31也可以是氢。R3、R5和R6独立地为氢，具有主链含有1至约20个碳原子的脂肪基团，脂环基团，芳香基团，芳基脂基团或芳基脂环基团，包括0至约3个从N、O、S、Se和Si组成的杂原子。R4为具有主链含有1至约20个碳原子的脂肪桥，脂环桥，芳香桥，芳基脂桥或芳基脂环桥，包括0至约3个从N、O、S、Se和Si组成的杂原子，X为卤素。在式（XX）中，R30为—C(OH)R1R2或—COOR14，其中R1、R2和R14独立地为氢，具有主链含有1至约20个碳原子的脂肪基团，脂环基团，芳香基团，芳基脂基团或芳基脂环基团，包括0至约3个从N、O、S、Se和Si组成的杂原子。
• Conjugated nitroalkenes in cycloaddition reactions. Part 2. Diels–Alder reactions of E-2-aryl-1-cyano-1-nitroethenes with cyclopentadiene
  作者：Radomir Jasiński、Michał Rzyman、Andrzej Barański

  DOI：10.1135/cccc2009562

  日期：——

  The reaction between E-2-aryl-1-cyano-1-nitroethenes 1a–1e and cyclopentadiene (2) occurs according to the carbodiene [4+2]cycloaddition scheme and leads to the corresponding 6-endo-aryl-5-endo-cyano-5-exo-nitronorbornenes 3a–3e and 6-exo-aryl-5-exo-cyano-5-endo-nitronorbornenes 4a–4e as the only reaction products. The attempts to detect the products of heterodiene [4+2]cycloaddition in the reaction environment were not successful.

  E-2-芳基-1-氰基-1-硝基乙烯1a–1e和环戊二烯(2)之间的反应遵循碳二烯[4+2]环加成机制，生成相应的6-内取代芳基-5-内取代氰基-5-外取代硝基-壬二烯3a–3e和6-外取代芳基-5-外取代氰基-5-内取代硝基-壬二烯4a–4e作为唯一的反应产物。在反应环境中检测到异二烯[4+2]环加成的产物尝试失败。
• Kinetics of the [4+2] cycloaddition of cyclopentadiene with (E)-2-aryl-1-cyano-1-nitroethenes
  作者：Radomir Jasiński、Magdalena Kwiatkowska、Andrzej Barański

  DOI：10.1007/s00706-012-0735-3

  日期：2012.6

  AbstractThe electrophilicity of (E)-2-aryl-1-cyano-1-nitroethenes is not sufficient to induce a zwitterionic course of their [4+2] cycloaddition to cyclopentadiene. The one-step mechanism of these reactions is indicated by the activation parameters, and the substituent and solvent effects on the reaction. Graphical Abstract

  摘要（E）-2-芳基-1-氰基-1-硝基乙烯的亲电子性不足以诱导其[4 + 2]环加成到环戊二烯上的两性离子过程。这些反应的一步机制由活化参数以及取代基和溶剂对反应的影响指示。 图形概要
• PYRIMIDINE DERIVATIVES AND ANALOGS, PREPARATION METHOD AND USE THEREOF
  申请人：Xu Lifeng

  公开号：US20120178915A1

  公开（公告）日：2012-07-12

  This invention relates with the arylheterocycle-fused pyrimidines, derivatives and analogs of formula I: or stereoisomers, tautoers, prodrugs, pharmaceutically acceptable salts, complex salts or solvates thereof, wherein: A-cycle is of 3-8 saturated or unsaturated arylheterocycles or aliheterocyclic, containing 1-4 heteroatoms, B-cycle 5-8 member saturated or unsaturated heterocycle containing 1-4 heteroatoms; X 1 , X 2 , X 3 , X 4 are, independently at each occurrence, C, O, S, Se, N and P elements; R 1 , R 2 , R 3 is a substituent containing alicyclic group, arylcycle group, heterocyclic group, adamantane alkyl, adamantane heterocycle, adamantane analogs, sugar group, hydroxyl group, amino acid group or a combination of the above substituents. This invention also relates with their preparative methods and applications.

  该发明涉及与芳基杂环融合的嘧啶类化合物、衍生物和类似物的公式I：或其立体异构体、互变异构体、前药、药学上可接受的盐、复盐或溶剂化合物，其中：A环是由3-8个饱和或不饱和的芳基杂环或芳杂环组成，含有1-4个杂原子，B环是由5-8个成员的饱和或不饱和杂环组成，含有1-4个杂原子；X1、X2、X3、X4在每次出现时独立地是C、O、S、Se、N和P元素；R1、R2、R3是含有脂环基团、芳环基团、杂环基团、金刚烷烷基、金刚烷杂环、金刚烷类似物、糖基、羟基、氨基酸基团或上述基团的组合的取代基。该发明还涉及它们的制备方法和应用。